Plasma adrenomedullin level and year-by-year variability of body mass index in the general population.

Peptides
Johji KatoKazuo Kitamura

Abstract

Plasma levels of the hypotensive peptides of adrenomedullin and atrial and B-type natriuretic peptides (AM, ANP, BNP) are possible biomarkers for cardiovascular diseases. Increased variability of body mass index (BMI) over a certain period of time has been reported to be associated with cardiovascular morbidity or mortality. The aim of this study is to examine clinical significance of those hypotensive peptides as biomarkers by analyzing the relationship between plasma levels of the peptides and year-by-year variability of BMI in the general population without overt cardiovascular diseases. The subjects were 427 local residents (141 males and 286 females) attending their annual health check-up, who had been examined at least 5 times over the preceding period of 10 years. They were divided into two groups of low or high variability by the median of coefficient of variation (CV) of BMI values for each gender. Plasma AM levels of those with high year-by-year variability of BMI were significantly increased, as compared to the group with low variability, in both genders; meanwhile, such a difference was not noted in plasma levels of the natriuretic peptides. No significant differences were found in the basal parameters, which could ...Continue Reading

References

Jun 27, 1991·The New England Journal of Medicine·L LissnerK D Brownell
Jan 1, 1995·Life Sciences·B GumuselH Lippton
Apr 30, 1993·Biochemical and Biophysical Research Communications·K KitamuraT Eto
Nov 26, 1997·Lancet·M HayashiT Fujita
Jan 5, 2002·Circulation·Tatsuo ShimosawaToshiro Fujita
Jan 13, 2004·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Toshihiro KitaTanenao Eto
Jul 12, 2005·The Journal of Clinical Investigation·Nitish R MahapatraSushil K Mahata
Sep 6, 2005·Arteriosclerosis, Thrombosis, and Vascular Biology·Johji KatoTanenao Eto
Sep 13, 2005·Regulatory Peptides·Takuo NambuKazuwa Nakao
Apr 21, 2006·Journal of Human Hypertension·J KatoT Eto
Jun 24, 2006·European Journal of Endocrinology·O Paulmyer-LacroixM Grino
Dec 22, 2006·The New England Journal of Medicine·Thomas J WangRamachandran S Vasan
Aug 27, 2009·Regulatory Peptides·Ikuo NomuraKazuo Kitamura
Jul 29, 2010·Clinical and Experimental Hypertension : CHE·Maple M FungDaniel T O'Connor
Feb 13, 2013·Nature Reviews. Cardiology·Gianfranco ParatiGrzegorz Bilo
Jul 7, 2015·European Journal of Pharmacology·Johji Kato, Kazuo Kitamura
Apr 6, 2017·The New England Journal of Medicine·Sripal BangaloreDavid D Waters
Apr 27, 2017·Current Medicinal Chemistry·Sushil K MahataNitish R Mahapatra
Apr 27, 2019·Journal of the American Heart Association·Todd R SponholtzRamachandran S Vasan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.